Medical and Dental Consultantsí Association of Nigeria
Home - About us - Editorial board - Search - Ahead of print - Current issue - Archives - Submit article - Instructions - Subscribe - Advertise - Contacts - Login 
  Users Online: 1127   Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Year : 2014  |  Volume : 17  |  Issue : 4  |  Page : 511-516

Clinical and laboratory experience of chorionic villous sampling in Nigeria

1 Department of Fetal Medicine, Fetal Medicine Unit; Department of Genetic Diagnosis, Molecular Diagnosis Laboratory, High Rocks Fetal Medicine and Genetic Diagnosis Centre, Oshodi Isolo, Lagos State, Nigeria
2 Department of Obstetrics and Gynaecology, Fetal Medicine Unit, Olabisi Onabanjo University Teaching Hospital, Sagamu, Ogun State, Nigeria

Correspondence Address:
O A Oloyede
Department of Obstetrics and Gynaecology, Fetal Medicine Unit, Olabisi Onabanjo University Teaching Hospital, Sagamu, Ogun State
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/1119-3077.134055

Rights and Permissions

Background: Chorionic villous sampling is a first trimester invasive diagnosis procedure that was introduced in Nigeria < 2 decades ago. Objective: The objective of the following study is to review experience with chorionic villous sampling in relation to clinical and laboratory procedures, including general characteristics of women, indications and outcome, complications, laboratory analysis and learning curve. Materials and Methods: Descriptive study of chorionic villous samplings between 2005 and 2012. Clinical and laboratory data were extracted from records. The women had trans-abdominal or trans-cervical procedure after counseling. Deoxyribonucleic acid extraction was by boiling method and molecular diagnosis by restriction fragment length polymorphism or quantitative fluorescence polymerase chain reaction. Analyzed data were presented using simple frequency tables. Results: A total of 426 women were analyzed. The major indications were Sickle cell anemia (97.2%), gender determination (1.9%) and aneuploidy (0.7%) respectively. Most procedures (71.2%) were done between 11 +0 and 13 +6 weeks by trans-abdominal approach (88.7%). Overall success at the first sampling was 98.8%. Error in laboratory diagnosis recorded in 3 (0.7%) pregnancies, while 5 (1.2%) were reanalyzed due to maternal decidua/inadequate fetal sample (0.7%) or failure of amplification (0.5%) respectively. Primary sex ratio was 5 (XY): 3 (XX). Down syndrome was the most common aneuploidy diagnosed with a detection rate of 66.7%. Learning curve was evident from reducing the incidence of abortion, number of aspirations and increasing success at the first attempt and villi yield. Conclusion: The present study shows acceptance and utilization of chorionic villus sampling and also demonstrates its safety and reliability.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded461    
    Comments [Add]    
    Cited by others 1    

Recommend this journal